Xilio Therapeutics, Inc.
XLO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$58 | -$76 | -$88 | -$76 |
| Dep. & Amort. | $2 | $2 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $0 | $0 | $5 |
| Change in WC | $32 | -$2 | $2 | -$12 |
| Other Non-Cash | $0 | $8 | $9 | $0 |
| Operating Cash Flow | -$18 | -$69 | -$76 | -$81 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$2 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$2 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3 | -$7 | -$0 | -$0 |
| Stock Issued | $7 | $0 | $0 | $116 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $26 | $0 | $0 | $144 |
| Financing Cash Flow | $29 | -$7 | -$0 | $261 |
| Forex Effect | $0 | -$0 | -$0 | $0 |
| Net Chg. in Cash | $11 | -$76 | -$78 | $179 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $46 | $120 | $198 | $21 |
| End Cash | $57 | $45 | $120 | $200 |
| Free Cash Flow | -$18 | -$69 | -$78 | -$82 |